These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 13406032)

  • 1. Relationships between chemical structure and psychoses with the use of psychotoxic substances; comparative pharmacopsychiatric analysis: a new research method.
    SOLMS H
    J Clin Exp Psychopathol; 1956; 17(4):429-33. PubMed ID: 13406032
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes.
    Ishii H; Niwaguchi T; Nakahara Y; Hayashi M
    J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds].
    Niwaguchi T; Nakahara Y; Ishii H
    Yakugaku Zasshi; 1976 May; 96(5):673-8. PubMed ID: 987200
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacopsychiatric study on a case of obsessive psychoneurosis; obsessive states during use of sympathomimetic drugs, amphetamine, LSD 25 & LAE 32.
    GIBERTI F; BREGORETTI L
    Sist Nerv; 1957; 9(4):275-88. PubMed ID: 13495598
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapeutic trials in psychosis. III. 2-Brom-d-lysergic acid diethylamide (BOL 148).
    TURNER WJ; MERLIS S
    Am J Psychiatry; 1958 Feb; 114(8):751-2. PubMed ID: 13498199
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of psychopathological factors & drug dosage in experimental psychoses].
    TONINI G
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):500-4. PubMed ID: 13466970
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of d-lysergic acid diethylamide and related compounds on melanophores].
    BERDE B; CERLETTI A
    Helv Physiol Pharmacol Acta; 1956; 14(3):325-33. PubMed ID: 13405353
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the pharmacology of D-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):114-30. PubMed ID: 13545891
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds.
    Ishii H; Hayashi M; Niwaguchi T; Nakahara Y
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1570-5. PubMed ID: 540347
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hydroxyzine hydrochloride on psychotoxic symptoms of lysergic acid diethylamide in normal human subjects].
    LOEB C; GIBERTI F
    Boll Soc Ital Biol Sper; 1956; 32(7-8):696-8. PubMed ID: 13404104
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids.
    CERLETTI A; DOEPFNER W
    J Pharmacol Exp Ther; 1958 Jan; 122(1):124-36. PubMed ID: 13502837
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of comparative pharmacopsychiatric analysis for the study of relations between chemical structure & psychosis in psychotoxic substances].
    SOLMS H
    Confin Neurol; 1958; 18(2-4):156-8. PubMed ID: 13597488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological trials concerning the mechanism of convulsions due to pure oxygen under pressure in mice].
    LABORIT H; BROUSSOLLE B; PERRIMOND-TROUCHET R
    J Physiol (Paris); 1957 Nov; 49(5):953-62. PubMed ID: 13514634
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts.
    ABRAMSON HA
    J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.